LONDON (Thomson Financial) - ClinPhone Plc. said its shareholders have
approved the acquisition of the company by Parexel International Holding U.K.
Ltd, an indirect wholly owned unit of Parexel International Corp.
On June 13, Parexel International said its 135 pence cash and share offer
for clinical trials technology rival ClinPhone had been accepted.
On July 7, the UK Office of Fair Trading invited comment on Parexel's
anticipated acquisition of ClinPhone.
tfn.newsdesk@thomson.com
pvi/ypv/ms1
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|